Monoterapi Induktionsbehandling, 1 dosis ugentligt til ialt 4 doser I det pivotale studie fik 166 patienter med recidiverende eller kemoterapi- resistent lavmalignt eller follikulært B- celle NHL 375 mg/ m2 MabThera som intravenøs infusion én gang om ugen i fire uger.
Monotherapy Initial treatment, weekly for 4 doses In the pivotal study, 166 patients with relapsed or chemoresistant low-grade or follicular B cell NHL received 375 mg/ m2 of MabThera as an intravenous infusion once weekly for four weeks.